Nihon Kohden Corporation (NHNKY)
OTCMKTS
· Delayed Price · Currency is USD
12.05
+0.07 (0.54%)
Apr 24, 2025, 3:45 PM EDT
Nihon Kohden Revenue
Nihon Kohden had revenue of 55.69B JPY in the quarter ending December 31, 2024, with 5.81% growth. This brings the company's revenue in the last twelve months to 224.29B, up 2.79% year-over-year. In the fiscal year ending March 31, 2024, Nihon Kohden had annual revenue of 221.99B with 7.45% growth.
Revenue (ttm)
224.29B JPY
Revenue Growth
+2.79%
P/S Ratio
1.40
Revenue / Employee
38.07M JPY
Employees
5,891
Market Cap
1.99B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 221.99B | 15.38B | 7.45% |
Mar 31, 2023 | 206.60B | 1.47B | 0.72% |
Mar 31, 2022 | 205.13B | 5.40B | 2.70% |
Mar 31, 2021 | 199.73B | 14.72B | 7.96% |
Mar 31, 2020 | 185.01B | 6.21B | 3.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |